Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hepatic Drug Clearance: Role of Transporters01:14

Hepatic Drug Clearance: Role of Transporters

295
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
295
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance01:07

Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance

273
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
273
Carrier-Mediated Transport01:06

Carrier-Mediated Transport

1.1K
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
1.1K
Nonlinear Pharmacokinetics: Role of Transporters01:27

Nonlinear Pharmacokinetics: Role of Transporters

275
A drug's nonlinear kinetics can be influenced by a diverse range of transporter proteins that serve as crucial players in drug distribution. These transporters, found within cells, can enhance or reduce local drug concentrations by facilitating the influx or efflux of drugs. For instance, the expression of xenobiotic transporters can be influenced by factors such as age and gender, potentially impacting the linearity of drug response.
Polymorphisms occurring in drug transporters can alter...
275
Factors Affecting Renal Clearance: Drug's Physicochemical Properties and Plasma Levels01:31

Factors Affecting Renal Clearance: Drug's Physicochemical Properties and Plasma Levels

578
Renal clearance of a drug is influenced by various factors, including its physicochemical properties and plasma levels. These factors play a significant role in determining how efficiently the kidneys eliminate a drug.
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
578
Renal Drug Clearance: Overview01:06

Renal Drug Clearance: Overview

663
Renal clearance is a crucial parameter in pharmacokinetics that quantifies the rate at which the kidneys excrete a drug. It represents a constant fraction of the central volume of distribution containing the drug that the kidney eliminates per unit of time.
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
663

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

AI is Excellent at the Discovery and Identification of Unrecognized Scientific Knowledge but There Is No Evidence That AI Can Create New Scientific Knowledge.

Journal of clinical pharmacology·2026
Same author

Mathematical Modeling in Drug Metabolism and Pharmacokinetics: Correct In Vitro, Not Always Valid In Vivo.

Pharmaceuticals (Basel, Switzerland)·2026
Same author

Simplifying Pharmacokinetics, Applying it to Drug and Dosage Form Development, and Making Drug Dosage Decisions in Clinical Medicine: The Adaptation of Kirchhoff's Laws from Physics.

The AAPS journal·2025
Same author

Response to the commentary on "are all measures of liver Kp<sub>uu</sub> a function of F<sub>H</sub>, as determined following oral dosing, or have we made a critical error in defining hepatic drug clearance?"

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2025
Same author

Application of Kirchhoff's Laws to pharmacologic and pharmacokinetic analyses.

Pharmacological reviews·2025
Same author

Evaluating <i>in vivo</i> data for drug metabolism and transport: lessons from Kirchhoff's Laws.

Frontiers in pharmacology·2024

Related Experiment Video

Updated: Jan 14, 2026

Models and Methods to Evaluate Transport of Drug Delivery Systems Across Cellular Barriers
18:57

Models and Methods to Evaluate Transport of Drug Delivery Systems Across Cellular Barriers

Published on: October 17, 2013

47.2K

Net Influx Rather Than Directional Rates: Re-evaluating Transporter Characterization In Vivo and In Vitro for Renal

Leslie Z Benet1, Jasleen K Sodhi2,3

  • 1Department of Bioengineering and Therapeutic Sciences, Schools of Pharmacy and Medicine, University of California San Francisco, San Francisco, CA, 94143-0912, USA. Leslie.Benet@ucsf.edu.

The AAPS Journal
|October 23, 2025
PubMed
Summary

This study challenges the Extended Clearance Concept (ECC), showing hepatic clearance depends on net transporter activity, not just influx. Our new framework offers a more accurate interpretation of drug disposition and transporter roles.

Keywords:
Hepatic clearanceKirchhoff’s LawsNet influxRenal clearanceTransporters

More Related Videos

An In Vivo Method for Evaluating the Gut-Blood Barrier and Liver Metabolism of Microbiota Products
14:54

An In Vivo Method for Evaluating the Gut-Blood Barrier and Liver Metabolism of Microbiota Products

Published on: October 20, 2018

8.9K
Setting-up an In Vitro Model of Rat Blood-brain Barrier BBB: A Focus on BBB Impermeability and Receptor-mediated Transport
16:26

Setting-up an In Vitro Model of Rat Blood-brain Barrier BBB: A Focus on BBB Impermeability and Receptor-mediated Transport

Published on: June 28, 2014

43.2K

Related Experiment Videos

Last Updated: Jan 14, 2026

Models and Methods to Evaluate Transport of Drug Delivery Systems Across Cellular Barriers
18:57

Models and Methods to Evaluate Transport of Drug Delivery Systems Across Cellular Barriers

Published on: October 17, 2013

47.2K
An In Vivo Method for Evaluating the Gut-Blood Barrier and Liver Metabolism of Microbiota Products
14:54

An In Vivo Method for Evaluating the Gut-Blood Barrier and Liver Metabolism of Microbiota Products

Published on: October 20, 2018

8.9K
Setting-up an In Vitro Model of Rat Blood-brain Barrier BBB: A Focus on BBB Impermeability and Receptor-mediated Transport
16:26

Setting-up an In Vitro Model of Rat Blood-brain Barrier BBB: A Focus on BBB Impermeability and Receptor-mediated Transport

Published on: June 28, 2014

43.2K

Area of Science:

  • Pharmacokinetics
  • Drug Metabolism
  • Physiologically Based Pharmacokinetic Modeling

Background:

  • The Extended Clearance Concept (ECC) often assumes hepatic uptake clearance is solely rate-limited by transporter influx.
  • Current interpretations may oversimplify complex drug disposition mechanisms.
  • Physiologically Based Pharmacokinetic (PBPK) analyses and experimental data have not definitively validated the ECC framework.

Purpose of the Study:

  • To challenge the assumption that hepatic uptake clearance is solely determined by transporter influx.
  • To develop a more robust and mechanistically consistent framework for interpreting renal and hepatic clearance.
  • To highlight the limitations of the ECC and current in vitro methods for assessing transporter function.

Main Methods:

  • Reviewing the derivation of renal and hepatic clearance using principles analogous to Kirchhoff's Laws.
  • Incorporating organ blood flow, transporter activity, and systemic drug delivery.
  • Analyzing the net difference between influx and efflux clearances as the determinant of transporter involvement.

Main Results:

  • Hepatic clearance data are adequately explained by a framework emphasizing the net difference between influx and efflux clearances.
  • The ECC framework's limitations in capturing all mechanistic elements of drug disposition are highlighted.
  • Current in vitro methods for determining hepatic influx and efflux clearances may not accurately quantify directional transport.

Conclusions:

  • The net difference between influx and efflux clearances, not influx alone, is the key determinant of transporter involvement in hepatic drug disposition.
  • A new derivation provides a more mechanistically sound approach to interpreting renal and hepatic clearance.
  • While PBPK and ECC are useful for predictions, model-based fitting does not equate to mechanistic validation.